bcl-2 and p53 protein expression in non-small cell lung cancers: Correlation with survival time

Clinical Cancer Research

Volumn 2, Issue 5, 1996, Pages 915-920

  Ohsaki, Yoshinobu ^a   Toyoshima, Eri ^a   Fujiuchi, Satoru ^a   Matsui, Hideo ^a   Hirata, Satoshi ^a   Miyokawa, Naoyuki ^a   Kubo, Yoshihiko ^a   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

AGED; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029940427     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., and Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cell with the t(14;18) chromosome translocation. Science (Washington DC), 226: 1097-1099, 1984.
2. Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C., and Mason, D. Y. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am. J. Pathol., 137: 225-232, 1990.
3. Wang, Y., Szekely, L., Okan, I., Klein, G., and Wiman, K. G. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene, 8: 3427-3431, 1993.
4. Korsmeyer, S. J. bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80: 879-886, 1992.
5. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., and Krosmeyer, S. J. Bcl-2 protein is topographically restricted in tissue characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88: 6961-6965, 1991.
6. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., and Mason, Y. Bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
7. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M., Rosenberg, R., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
8. Mitsudomi, T., Steinberg, S. M., Nau, M. M., Carbone, D., D'Amico, D., Bonder, S., Oie, H. K., Linnoila, R. I., Mulshine, J. L., Minna, J. D., and Gazdar, A. F. p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7: 171-180, 1992.
9. Davidoff, A. M., Humphrey, P. A., Iglehart, J. D., and Marks, J. R. Genetic basis for p53 overexpression in human breast cancer. Proc. Natl. Acad. Sci. USA, 88: 5006-5010, 1991.
10. Bartek, J., Bartkova, J., Vojtesek, B., Staskova, Z., Rejthar, A., Kovarik, J. and Lane, D. P. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int. J. Cancer, 46: 839-844, 1990.
11. Thor, A. D., Moore, D. H., II, Edgerton, S. M., Kawasaki, E. S., Reihsaus, E., Lynch, H. T., Marcus, J. N., Schwartz, L., Chen, L-C., Mayali, B. H., and Smith, H. S. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J. Natl. Cancer Inst., 84: 845-855, 1992.
12. Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
13. Visakorpi, T., Kallioniemi, O-P., Heikkinen, A., Koivula, T., and Isalo, J. Small subgroup of aggressive highly proliferative prostatic carcinomas defined by p53 accumulation. J. Natl. Cancer Inst., 84: 883-887, 1992.
14. Chang, F., Syrjanen, S., and Syrjanen, K. Implications of the p53 tumor-suppressor gene in clinical oncology J. Clin. Oncol., 13: 1009-1022, 1995.
15. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
16. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
17. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
18. Hall, P. A., McKee, P. H., Menage, H. P., Dover, R., and Lane, D. P. High levels of p53 in UV-irradiated normal human skin. Oncogene, 8: 203-207, 1993.
19. Silvestrini, R., Vereroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., Di Fronzo, G., Rilke, F., and Veronesi, U. The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J. Natl. Cancer Inst., 86: 499-504, 1994.
20. Piris, M. A., Pezella, F., Martinez-Montero, J. C., Orradre, J. L., Villuendas, R., Sanchez-Beato, M., Cuena, R., Cruz, M. A., Martinez, B., Garrido, M. C., Gatter, K., Aiello, A., Delia, D., Giardini, R., and Rilke, F. p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br. J. Cancer, 69: 337-341, 1994.
21. Ben-Ezra, J. M., Kornstein, M. J., Grimes, M M., and Krystal, G. Small cell carcinomas of the lung express the bcl-2 protein. Am. J. Pathol., 145: 1036-1040, 1994.
22. Kalbfleisch, L. D., and Prentice, R. L. (eds.). The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons, Inc., 1980.
23. Castle, V. P., Heidelberger, K. P., Bromberg, J., Ou, X., Dole, M., and Nunez, G. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am. J. Pathol., 143: 1543-1550, 1993.
24. Hague, A., Moorghen, M., Hicks, D., Chapman, M., and Paraskeva, C. bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene, 9: 3367-3370, 1994.
25. Leek, R. D., Kaklamanis, L., Pezzella, F., Gatter, K. C., and Harris, A. L. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br. J. Cancer, 69: 135-139, 1994.
26. McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C., Chung, L. W. K., Hsieh, J-T., Tu, S-M., and Campbell, M. L. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940-6944, 1992.
27. Hiyoshi, H., Matsuno, Y., Kato, H., Shimosato, Y., and Hirohashi, S. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn. J. Cancer Res., 83: 101-106, 1992.
28. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
29. Miyashita, T., Harigai, M., Hanada, M., and Reed, J. C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 54: 3131-3135, 1994.
30. Levine, A. J. The p53 tumor-suppressor gene. N. Engl. J. Med., 326: 1350-1352, 1992.
31. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A. J., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
32. Li, F. P., Fraumeni, J. F. J., Mulvihill, J. J., Blattner, W. A., Dreyfus, M. G., Tucker, M. A., and Miller, R. W. A cancer family syndrome in twenty-four kindreds. Cancer Res., 48: 5358-5362, 1988.
33. Srivastava, S., Zou, Z. Q., Pirollo, K., Blattner, W. A., and Chang, E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (Lond.), 348: 747-749, 1990.
34. Sachs, L., and Lotem, J. Control of programmed cell death in normal and leukemic cells: new implications for therapy Blood, 82: 15-21, 1993.
35. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.